POSCO International, South Korea's largest trading company with $22.2 billion in revenue last year, is tokenizing live trade receivables on the Injective blockchain in a pilot with LG CNS. The initiative places real commercial invoices from POSCO's overseas operations onto a shared ledger, creating a single transferable record that embeds compliance rules and reduces reconciliation times for buyers, sellers and banks. POSCO plans to move the pilot into live production after completing it later this year. This is another corporate blockchain deployment in South Korea, where Hyundai recently began using stablecoins for treasury transfers and Circle partnered with Kakao and Toss Bank on payment infrastructure.
The shift from tokenizing funds and equities to tokenizing receivables suggests blockchain rails are moving deeper into corporate finance. Trade receivables represent real commercial obligations, allowing companies to move working capital more efficiently while giving banks and financing partners a shared view of the asset. LG CNS has previously worked on the Bank of Korea's CBDC pilot and operates tokenization platforms for KOSCOM and Mirae Asset Securities. The market for tokenized assets currently stands at $35 billion, with Citi estimating it could reach $5.5 trillion by 2030.
For traders, this matters as adoption signal rather than immediate price catalyst. Corporate treasury deployments by major conglomerates validate blockchain infrastructure in a category that has nothing to do with speculation or retail sentiment. Injective's selection by POSCO and LG CNS indicates the chain's enterprise credibility in a market where infrastructure competition is intense. The pilot uses real receivables, not simulated transactions, which differentiates it from earlier proof-of-concept work that rarely moved to production. If POSCO does transition to live deployment, it would represent a tangible revenue-generating use case for the chain.
The signal to watch is whether POSCO announces full production rollout and whether other South Korean conglomerates follow. Corporate adoption moves slowly but compounds when peers validate a platform. Injective funding sits at +0.6bp/8h against a 30-day average of +0.1bp, indicating elevated cost to hold longs but not extreme. Fear and Greed reads 30, modestly above the 30-day average of 23, reflecting a market that is cautious but not panicked. If more enterprise names surface using Injective for trade finance or treasury operations in the next quarter, that would shift the token's narrative from DeFi infrastructure to dual-use corporate rails. No position until production deployment is confirmed and peer adoption emerges.
Source: CoinDesk